CTOs on the Move

Outcome Concept Systems

www.ocsys.biz

 
Outcome Concept Systems is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ocsys.biz
  • 1818 E Mercer St
    Seattle, WA USA 98112
  • Phone: 206.325.3396

Executives

Name Title Contact Details

Similar Companies

ResearchPoint Global

ResearchPoint Global is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeoPath Health

NeoPath Health is a Hopkins, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Innovative Product Achievements, LLC

Innovative Product Achievements, LLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Duluth, GA. To find more information about Innovative Product Achievements, LLC, please visit www.thinkipa.com

MTX Therapy Services

MTX Therapy Services is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Volition

Volition is a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. Early diagnosis and monitoring have the potential to not only prolong the life of patients but also improve their quality of life. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring. Volition`s research and development activities are centered in Belgium, with an innovation laboratory in California and additional offices in Texas, London, and Singapore, as the company focuses on bringing its diagnostic and disease monitoring products to market.